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Powered by the mitochondrial membrane potential, Ca2+ permeates the mitochondria via a Ca2+ channel termed Ca2+ uniporter 
and is pumped out by a Na+/Ca2+ exchanger, both of which are located on the inner mitochondrial membrane. Mitochondrial 
Ca2+ transients are critical for metabolic activity and regulating global Ca2+ responses. On the other hand, failure to control 
mitochondrial Ca2+ is a hallmark of ischemic and neurodegenerative diseases. Despite their importance, identifying the uni-
porter and exchanger remains elusive and their inhibitors are non-specific. This review will focus on the mitochondrial ex-
changer, initially describing how it was molecularly identified and linked to a novel member of the Na+/Ca2+ exchanger super-
family termed NCLX. Molecular control of NCLX expression provides a selective tool to determine its physiological role in a 
variety of cell types. In lymphocytes, NCLX is essential for refilling the endoplasmic reticulum Ca2+ stores required for anti-
gen-dependent signaling. Communication of NCLX with the store-operated channel in astroglia controls Ca2+ influx and 
thereby neuro-transmitter release and cell proliferation. The refilling of the Ca2+ stores in the sarcoplasmic reticulum, which is 
controlled by NCLX, determines the frequency of action potential and Ca2+ transients in cardiomyocytes. NCLX is emerging 
as a hub for integrating glucose-dependent Na+ and Ca2+ signaling in pancreatic β cells, and the specific molecular control of 
NCLX expression resolved the controversy regarding its role in neurons and β cells. Future studies on an NCLX knockdown 
mouse model and identification of human NCLX mutations are expected to determine the role of mitochondrial Ca2+ efflux in 
organ activity and whether NCLX inactivation is linked to ischemic and/or neurodegenerative syndromes. Structure-function 
analysis and protein analysis will identify the NCLX mode of regulation and its partners in the inner membrane of the mito-
chondria.  
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The mitochondrion is not only the energy supplier of the 
cell, but also a major Ca2+ signaling hub. Powered by the 
steep mitochondrial membrane potential, Ca2+ permeates 
through a Ca2+ channel traditionally called the Ca2+ uni-
porter [1,2], and then is pumped out by a 3Na+/1Ca2+ ex-
changer [3,4], or in some cells by a H+/Ca2+ exchanger [5,6]. 
Although the functional elements of mitochondrial Ca2+ 
shuttling were discovered many years ago, their physiolog-
ical relevance remained questionable for many years, be-
cause of their low Ca2+ affinity at the range of micromolar 
compared with the magnitude of Ca2+ transients recorded in 
the cytosol of most cell types. The pioneering work of Tulio 
Pozzan and Rossario Rizzuto, who were first to monitor in 
situ mitochondrial Ca2+ using the mitochondrial-targeted 
Ca2+ sensor, aequorin, showed that almost any Ca2+ re-
sponse is propagated by a mitochondrial Ca2+ transient [7]. 
The apparent discrepancy between the low affinity of the 
mitochondrial Ca2+ influx and its frequent role in Ca2+ re-
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sponse has been resolved by high-resolution imaging, which 
revealed that cellular Ca2+ responses are highly heteroge-
neous and in fact Ca2+ reaches micromolar levels at cellular 
microdomains, also called hot spots, particularly at the vi-
cinity of the plasma membrane and endoplasmic reticulum 
(ER) [8,9]. This major breakthrough was followed by a 
dramatic surge in interest and studies aimed at determining 
the role of mitochondria in cellular Ca2+ signaling. These 
studies, which are described in many excellent reviews, 
found that the mitochondria are a major and critical cellular 
Ca2+ signaling hub, mediating crosstalk particularly with the 
ER and plasma membrane domains [1012]. By controlling 
cellular Ca2+ signals, the mitochondria control principal 
physiological processes ranging from hormonal secretion to 
cardiac and neuronal activity. In addition, mitochondrial 
Ca2+ overload is a preceding hallmark event in necrotic or 
apoptotic cell death during ischemic and neurodegenerative 
syndromes. Thus, fully coordinated activity of the uniporter 
and exchanger is required to prevent these processes [13]. A 
major limitation, however, in investigating in detail the mo-
lecular events linked to the role of mitochondria in physio-
logical processes and how they break down during diseases 
was that the identities of the mitochondrial uniporter and 
exchanger were unknown. An additional hurdle was that the 
inhibitors used to determine their role were not highly se-
lective and interacted with other major Ca2+ channels or 
transporters at similar concentrations required to block the 
exchanger.  
The last four years were a period of dramatic changes 
and progress, because of the molecular identification of the 
exchanger and uniporter. Novel insight is emerging on their 
molecular regulation, and precise molecular tools are now 
available to control their activity and expression. The uni-
porter was identified following an ingenious mitochondrial 
proteomic study that sought to fish out mitochondrial pro-
teins linked to mitochondrial Ca2+ shuttling found in mam-
mals but not in yeast, for example. This screen first led to 
the identification of the Ca2+ uniporter inhibitor, MICU1 
[14], and then to the identification of the Ca2+ uniporter it-
self, MCU, by the groups of Mootha and Rizzuto [1,2]. 
Many excellent reviews have been published on the physi-
ological and molecular aspects of MCU in health and dis-
eases [1517]. Here, we will first describe how NCLX was 
identified, and then describe novel molecular and physio-
logical aspects that were discovered after its identification.  
1  Identification of the mitochondrial NCLX  
The functional phenomenon of Na+-dependent Ca2+ release 
underlying the exchanger activity was first discovered 40 
years ago by Ernesto Carfoli in cardiac mitochondria [3]. A 
unique ionic property of this exchanger that was later used 
for its molecular identification was that in contrast to other 
Na+/Ca2+ exchanger superfamily members, such as NCX 
and NCKX that are inert to Li+, it could catalyze Li+- and 
Na+-dependent Ca2+ exchange at similar rates. This study 
was later followed by purification and functional reconstitu-
tion of a putative 60-kD polypeptide thought to be related to 
the mitochondrial exchanger [18]. However, this did not 
lead to the molecular identification of the mitochondrial 
exchanger. The identification of the mitochondrial Na+/Ca2+ 
exchanger gene began when we attempted to find the gene 
responsible for a Na+/Zn2+ exchange activity in HEK 293 
cells and neurons. The rationale behind our strategy was 
that the Na+/Zn2+ exchanger may be a member of the 
Na+/Ca2+ exchanger superfamily. We cloned a putative can-
didate termed FLJ22233. Phylogenetic analysis of this can-
didate indicated that it is more ancestral than the NCX and 
NCKX families, but it shares with them the same 1 and 2 
domains that form the catalytic cation transport site. We 
then expressed this putative gene in cells and asked if its 
expression is linked to Zn2+ transport. To our disappoint-
ment at the time, FLJ22233 expression was not linked to 
Zn2+ transport. We then turned to Ca2+ and found that it me-
diated Na+/Ca2+ exchange. One of the classic controls for 
analyzing Na+-dependent Ca2+ transport is to replace Na+ 
with Li+. The latter ion is inert to NCX and NCKX. To our 
surprise, we found that Li+ supported Ca2+ efflux in cells 
expressing FLJ22233 almost at the same potency as that of 
Na+. We then realized that the mitochondrial Na+/Ca2+ ex-
changer was not selective to Li+ [19]. We then set out to 
determine whether FLJ22233, now called NCLX 
(Na+/Li+/Ca2+ exchanger), is found in the mitochondria by 
Western blot and electron microscopy-based immunological 
analysis and found that NCLX is not only enriched in the 
mitochondrial fraction but is also found in the inner mito-
chondrial membrane. Subsequent functional experiments 
using the inner mitochondrial-targeted Ca2+ sensor, mi-
to-pericam, showed that mitochondrial expression of NCLX 
triggered an accelerated Ca2+ efflux that was fully blocked 
by this exchanger’s inhibitor, CGP-37157. Importantly, the 
endogenous mitochondrial Ca2+ efflux activity could be 
blocked by reducing NCLX expression by RNAi using 
siNCLX or shNCLX constructs, or by expressing an NCLX 
mutation at the catalytic 1 domain. The effect of the latter 
is presumably mediated by a strong dominant negative ef-
fect of the mutation, which is related to the dimeric func-
tional organization of NCLX. Finally, our results indicated 
that the mitochondrial Ca2+ efflux mediated by NCLX fully 
depends on the transpresence of Na+, and that mitochondrial 
Ca2+ efflux by NCLX is coupled to Na+ influx. Remarkably, 
Li+ could effectively replace Na+ in promoting mitochon-
drial Ca2+ efflux. Thus, the fortuitous mislocalization of 
NCLX to the cell membrane induced by overexpression in 
HEK 293 cells led to the identification that NCLX is the 
long-sought mitochondrial Na+/Ca2+ exchanger [4]. In the 
following, we will describe some of the studies using the 
molecular tools derived from NCLX identification and dis-
cuss their physiological implications.  
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2  NCLX controls antigen-dependent Ca2+ re-
sponse in lymphocytes  
Ca2+ is a major second messenger in lymphocytes. Binding 
of antigens to their receptors triggers a robust Ca2+ response 
that is controlled by the crosstalk between the store-    
operated Ca2+ pathway, which consists of two major com-
ponents. The first is STIM, a Ca2+ sensor in the ER that up-
on depletion of the ER stores forms dimers that activate the 
store-sensitive plasma membrane Ca2+ channel, Orai. The 
second component is the ER, a major store of Ca2+ that re-
leases Ca2+ upon activation of the inositol trisphosphate 
(IP3) receptor Ca2+ channel on the ER. Interestingly, the 
mitochondria network is highly dynamic in lymphocytes 
and often moves toward the immunological synapse partic-
ipating in Ca2+ signaling in these cells [20]. In their study, 
Kim et al. used DT40, a haploid lymphocytic cell line with 
a specific NCLX knockdown. They found that following 
NCLX knockdown the mitochondrial Ca2+ efflux was com-
pletely blocked, thus confirming the role of NCLX as a mi-
tochondrial exchanger and a major Ca2+ efflux pathway. 
Remarkably, they also found that the cytosolic anti-
gen-dependent Ca2+ response was fully blocked. By moni-
toring the cytosolic and ER Ca2+ response, they concluded 
that the reduction in the cytosolic Ca2+ signal was linked to 
impaired refilling of the ER store. Indeed, they demonstrat-
ed a tight physical interaction between the ER and mito-
chondria in lymphocytes. These findings are consistent with 
previous studies that showed a direct Ca2+ transport route 
between the mitochondria and ER, suggesting that NCLX 
activity is an important component in mitochondria to ER 
Ca2+ passage [21,22]. Depletion of the ER Ca2+ stores is 
likely to activate the store-operated Ca2+ channel. It will be 
interesting to determine how this pathway is affected by the 
activity of NCLX.  
3  NCLX and Ca2+ signaling in astrocytes  
Ca2+ signaling is also central in controlling astrocyte func-
tion and in mediating astrocyte-neuron communication. 
However, although the activity of the mitochondrial ex-
changer in response to glutamate signaling has been sug-
gested [23], its role in shaping global astrocytic Ca2+ sig-
naling or in controlling their executive functions is un-
known. To determine whether NCLX is expressed and 
whether its expression can be molecularly controlled in as-
trocytes, Parnis et al. [24] conducted Western blot analysis 
of siControl- versus siNCLX-treated astrocytes and found 
that it localized in the astrocyte’s mitochondria and its ex-
pression could be molecularly controlled. To determine its 
role in controlling the ER versus the store-operated Ca2+ 
channel, the cytosolic Ca2+ response was monitored in the 
presence or absence of extracellular Ca2+. Remarkably and 
in contrast to the results obtained in lymphocytes, the 
knockdown of NCLX expression changed the cytosolic Ca2+ 
response only in the presence of extracellular Ca2+, indicat-
ing that it primarily shapes the store-operated Ca2+ response. 
Indeed, a parallel experiment monitoring the mitochondrial 
Ca2+ response indicated that the store-operated Ca2+ re-
sponse evoked a much greater mitochondrial Ca2+ response 
compared with that by an ER-evoked signal. The diverse 
effects of NCLX activity in lymphocytes compared with 
astrocytes indicate that NCLX in particular and the mito-
chondria in general have a highly versatile role in control-
ling Ca2+ signaling in various cell types. This study further 
determined how NCLX is linked to the executive function 
of glial cells. A major finding of this study was that while 
NCLX does not play a major role in controlling the me-
chanically evoked Ca2+ wave that primarily originates in the 
ER store, it has a profound effect on astrocytic glutamate 
release. The latter function is required for glia-neuron 
communication. Because the secretory process depends on 
Ca2+ signaling at the plasma membrane domain, it involves 
the dominant role of NCLX in regulating the store-operated 
Ca2+ response. In addition, NCLX activity or expression is 
linked to the proliferation and migration of astrocytes. Sim-
ilarly to secretory processes, this function strongly depends 
on Ca2+ signaling that initiates at the plasma membrane do-
main. An open and intriguing question is the role of this 
exchanger in neurons, and the same strategy can now be 
used to study the neuronal role of mitochondrial Na+/Ca2+ 
exchange.  
4  The mitochondrial Na+/Ca2+ exchange in Ca2+ 
signaling is linked to insulin secretion  
The link between metabolic activity and Ca2+ signaling is 
fundamental in pancreatic β cells. The textbook dogma for 
insulin secretion is that the enhanced formation of ATP by 
glucose entry leads to closure of the K+-ATP channel, cul-
minating in the activation of the voltage-gated Ca2+ channel, 
and the subsequent rise in Ca2+ triggers insulin secretion 
[25]. Although the mitochondrial Ca2+ signal has a profound 
role in controlling ATP production, this aspect is much less 
understood. Two conflicting papers were published on the 
role of the mitochondrial exchanger in insulin secretion. 
The first study reasoned that because this exchanger lowers 
mitochondrial Ca2+ blocking, its activity can be used to en-
hance ATP production and thereby insulin secretion. Con-
sistent with this hypothesis, application of the mitochondrial 
exchanger blocker, CGP-37157, in cell culture and in vivo 
augmented metabolic activity and insulin secretion, indicat-
ing that blocking the exchanger can be used as a therapeutic 
strategy [26]. Although CGP-37157 is a potent blocker of 
the mitochondrial Na+/Ca2+ exchanger, a growing number of 
studies have reported that it is a high-affinity blocker of the 
L-Type Ca2+ channels [27]. Consistent with this concern, a 
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study that monitored the glucose-dependent cytosolic Ca2+ 
response suggested that application of CGP-37157 lowered 
the Ca2+ signal in pancreatic β cells by blocking the L-Type 
Ca2+ channel [28].  
To address the limitation and concern of using exchanger 
blockers, the role of NCLX was revisited using the RNA 
interference and dominant negative molecular tools aimed 
to control its expression and activity. Lowering NCLX ex-
pression and activity in the pancreatic β cell line, MIN6, or 
in primary pancreatic β cells was followed by a reduction in 
mitochondrial Ca2+ efflux. Notably, reducing NCLX ex-
pression or activity was followed by a reduction in the glu-
cose-dependent mitochondrial Ca2+ efflux. Remarkably, 
knocking down NCLX activity was followed by attenuation 
of the rate of the glucose-dependent Ca2+ rise, indicating 
that mitochondrial Ca2+ shuttling is required for enhancing 
the glucose-dependent cytosolic Ca2+ response. Analysis of 
the metabolic rate indicated that knocking down the expres-
sion of NCLX reduced the basal metabolic rate and had no 
effect on the glucose-dependent rise in metabolic activity. 
Thus, these results indicate that knockdown of NCLX activ-
ity, in contrast to results obtained by blockers, does not have 
the potential to boost glucose-dependent ATP production 
[29]. Consistent with the role of NCLX in upregulating the 
glucose-dependent cytosolic Ca2+ rise, knockdown of 
NCLX expression reduced the initial rate of glu-
cose-dependent insulin secretion. The latter effect is con-
sistent with the need for a robust Ca2+ rise to activate the 
first phase of insulin secretion [30].  
While most of the attention is focused on the role of the 
exchanger in Ca2+ signaling, it is important to remember 
that it is also a major Na+ transporter that passes at least 
three Na+ cations per one Ca2+ cation and that it constitutes 
the major mitochondrial Na+ uptake pathway. Another ma-
jor but poorly studied Na+ pathway in pancreatic β cells is 
the voltage-gated Na+ channels. Using TTX, a selective 
toxin blocker of these channels, and by molecularly control-
ling the expression of the mitochondrial uniporter, MCU, 
and of NCLX, we asked whether a Na+-dependent crosstalk 
between the plasma membrane and the mitochondrial do-
main controls the glucose-dependent Ca2+ signaling. Glu-
cose application was followed by a rise in cytosolic Na+ that 
was blocked by TTX, indicating that this channel mediates a 
glucose-dependent cytosolic Na+ signaling. The cytosolic 
Na+ signal was followed by mitochondrial Na+ uptake that 
was blocked by knockdown of NCLX expression, indicating 
that it is the major Na+ influx pathway in mitochondria. Na+ 
channels also elicit a strong glucose-dependent Ca2+ rise by 
depolarizing the cells and thereby strongly upregulating the 
firing rate and Ca2+ influx of the L-Type Ca2+ channels. 
This cytosolic Ca2+ response was propagated by mitochon-
drial Ca2+ uptake that was followed by enhanced metabolic 
activity and ATP production. The parallel activation of the 
mitochondrial NCLX paces the duration of the mitochon-
drial Ca2+ transient. Thus, the voltage-gated Na+ channels 
play a dual role in pancreatic β cells in triggering Na+ and 
Ca2+ signals. Both signals propagate into the mitochondria 
and control the metabolic activity, thereby controlling met-
abolic activity and secretion [31].    
5  The role of NCLX in neurons and the use of 
exchanger inhibitors  
Reversal of the plasma membrane exchanger in cardiomy-
ocytes and neurons can trigger a cytosolic Ca2+ overload 
that is linked to cardiac and brain damage. Studies using the 
mitochondrial exchanger blocker have assigned a similar 
role to the mitochondrial Na+/Ca2+ exchanger in this   
process. These studies, which used CGP-37157, suggested 
that using this blocker protected neurons in brain slices  
undergoing ischemic insults. To determine whether the 
CGP-37157 effect is linked to its effect on the exchanger  
or on the L-Type Ca2+ channel, the effect of CGP-37157 
was compared with that of the classical dihydropyridine 
blockers of the L-Type Ca2+ channel on mitochondrial   
and cytosolic responses under normal and toxic conditions. 
While CGP-37157 effectively reduced the mitochondrial 
Ca2+ efflux, it also reduced the cytosolic Ca2+ rise and  
neuronal cell death. The latter effect could be fully repro-
duced by nifedipine, a classical L-Type Ca2+ channel block-
er that does not modulate NCLX activity [32]. This study, 
therefore, warrants reconsideration of the role of the    
exchanger in neuronal survival by molecular tools aimed at 
controlling NCLX expression or by an NCLX knockdown 
mouse model.   
6  The cardiac role of NCLX 
Because of the rapid pacing and energy requirements of the 
heart, the mitochondrial Ca2+ transport via the Na+/Ca2+ 
exchanger that couples Na+ and Ca2+ exchange is of partic-
ular interest. Several intriguing studies have focused on the 
role of this exchange in ischemia and suggested that the rise 
in cytosolic Na+ encountered during ischemic insult may 
enhance the exchange activity, thus depleting mitochondrial 
Ca2+, leading to downregulation of the metabolic rate and 
ATP production [33,34]. Studies performed on tissue frac-
tions obtained from cardiac tissue have, however, suggested 
that CGP-37157 also interacts with the ryanodine receptor, 
SERCA, and the L-Type Ca2+ channel in this tissue [35]. 
Therefore, molecular control is particularly important for 
determining the mitochondrial exchanger role in this tissue. 
A recent study has started to address this concern by molec-
ularly controlling NCLX expression in the cardiomyocyte 
cell line, HL-1 [36]. This study has shown that siNCLX can 
be effectively used to control NCLX expression and to con-
trol its activity in cardiac mitochondria. The knockdown of 
NCLX expression was followed by a rise in basal free mi-
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tochondria Ca2+ level. Remarkably, knockdown of NCLX 
was followed by a change in the kinetic parameters of ac-
tion potential and Ca2+ transients. In particular, the cycle 
length of action potential and Ca2+ transients was prolonged. 
The authors suggested that the NCLX effect on these kinetic 
parameters is linked to its role in controlling the refilling of 
the sarcoplasmic reticulum (SR) Ca2+ stores. Knockdown of 
NCLX expression was followed by a strong decrease in 
refilling the SR Ca2+ stores, thus lowering the SR free Ca2+ 
content and SR ability to take up Ca2+. Thus, this study in-
dicates that the interaction of the mitochondrial exchanger 
with the SR Ca2+ stores plays a general role in cardiac pac-
ing. There are, however, major morphological and function-
al differences among cell line, primary cardiomyocytes and 
cardiac tissue, as well as major morphological and func-
tional differences regarding the interaction of SR with the 
cytosolic and plasma membrane. In addition, whether mi-
tochondria regulate cytosolic Ca2+ on a bit-to-bit basis is 
controversial. Therefore, viral vector and mouse knockdown 
models will be required to address the physiological role of 
NCLX in the heart and its importance during pathophysio-
logical syndromes. 
7  The role of the mitochondrial Na+/Ca2+ ex-
changer, NCLX, versus H+/Ca2+ exchanger in 
mitochondrial Ca2+ signaling  
Mitochondrial Ca2+ efflux is thought to be mediated by two 
pathways, the Na+/Ca2+ exchanger, NCLX, and the H+/Ca2+ 
exchanger. Leucine zipper, EF-hand, transmembrane mito-
chondrial protein 1 (Letm1) emerged as a candidate trans-
porter for mediating H+/Ca2+ exchange [6]. While Letm1 
was first shown to mediate K+/H+ exchange [37], subse-
quent studies suggested that it mediates an electrogenic ru-
thenium red-sensitive H+/Ca2+ exchange [6]. Subsequent 
studies performed on purified and reconstituted Letm1 at a 
higher density indicated that it mediates a very slow (two 
cycles s1) electroneutral ruthenium red-insensitive 2H+/Ca2+ 
exchange [5]. To compare their role in Ca2+ transport, 
NCLX and Letm1 were expressed in HeLa cells and their 
mitochondrial transport rate was determined. Overexpres-
sion of NCLX increased the rate of mitochondrial Ca2+ ef-
flux, while overexpression of Letm1 had no apparent effect 
[38]. The estimated turnover rate of NCLX is at least 1000 
cycles per second, and its electrogenic 3Na+/Ca2+ transport 
mode indicates that it can effectively use the steep-180 mV 
mitochondrial membrane potential to pump Ca2+ out of the 
mitochondria. The low electroneutral mode of operation 
(two cycles s1) of Letm1 suggests that it has a much lower 
capacity of mediating mitochondrial Ca2+ efflux. Thus, the 
physiological relevance of Ca2+ transport mediated by 
Letm1 remains to be determined. Further analysis of pri-
mary liver tissue, where mitochondrial H+/Ca2+ exchange is 
most convincing, can also be highly informative for ad-
dressing the elusive role of this transporter and to determine 
whether the major activity is K+/H+ or 2H+/Ca2+ exchange.  
8  Conclusion and future directions  
The original identification of NCLX as a mitochondrial ex-
changer is now supported by several studies that molecu-
larly linked it to the mitochondrial Na+/Ca2+ exchange in 
multiple cell types ranging from neurons to pancreatic β 
cells, lymphocytes and cardiomyocytes. Several studies 
have also highlighted the risk of solely relying on the phar-
macological inhibition of this exchanger by CGP-37157. 
While the latter is a highly potent blocker of the mitochon-
drial exchanger, it is also an effective inhibitor of other ma-
jor Ca2+ pathway components, most notably the L-Type 
Ca2+ channel. Several studies have indicated that the con-
troversy regarding the role of the exchanger in pancreatic β 
cells or during brain ischemia may at least be partly related 
to the effect of CGP-37157 on the Ca2+ channel. Molecular 
3D modeling of NCLX based on the resolved structure of 
other NCX membranes can provide a platform for novel 
agonists and antagonists that may be more selective. 
Despite the considerable progress made, there are many 
unresolved questions regarding the mode of NCLX activity 
and its physiological role that need to be addressed. Some 
examples are as follows: 
(i) Mode of NCLX regulation. The NCX members of the 
Na+/Ca2+ exchange family use an allosteric Ca2+-binding 
domain called CBD that plays a critical role in controlling 
the activity of this exchanger [39]. NCLX does not have a 
similar domain; however, previous studies have suggested 
that the mitochondrial Na+/Ca2+ exchange may be regulated 
by kinases such as protein kinase C and Pink-1 [40]. In silico 
analysis of the NCLX sequence indicated that it has several 
putative kinase-binding or phosphorylation sites, and bio-
chemical analysis can now be combined with physiological 
monitoring of NCLX activity, to determine the major regu-
latory factors and their mode of regulation.  
(ii) The NCLX counter partner MCU interacts with sev-
eral accessory units, among them MICU1 and MCU1 that 
have a profound effect on its activity. In fact, MCU is part 
of a multi-protein complex [1]. Considering the major role 
of mitochondrial Ca2+ efflux, it is therefore plausible that 
NCLX is part of this or another complex that controls mi-
tochondrial Na+/Ca2+ exchange. Therefore, proteomic anal-
ysis of mitochondrial proteins that interact with NCLX and 
functional studies of their physiological importance are of 
high priority. 
Analysis of MCU mouse knockdown and human subjects 
with MCU mutations suggests that it is of particular im-
portance for skeletal muscle and brain activity [41,42]. It 
will be interesting to see whether a similar phenotype will 
be found for NCLX or whether NCLX deficiency will be 
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linked to a distinct set of functions. Another intriguing con-
cept is whether mutations that hinder NCLX expression 
and/or activity are associated with human diseases, particu-
larly those associated with mitochondrial Ca2+ overload. The 
identification of NCLX finally enables us to address this 
issue and work is in progress to understand its physiological 
role and pathophysiological implications.   
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